Viewing Study NCT00485771



Ignite Creation Date: 2024-05-05 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00485771
Status: COMPLETED
Last Update Posted: 2007-06-13
First Post: 2007-06-11

Brief Title: OlanzapineFluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Study Overview

Official Title: OlanzapineFluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression
Status: COMPLETED
Status Verified Date: 2007-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to assess olanzapinefluoxetine combination and lamotrigine comparative efficacy safety and tolerability in acute and longer term treatment of bipolar depression
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
H6P-US-HDAQ None None None